Literature DB >> 31274357

Automatic speech recognition: A primer for speech-language pathology researchers.

Joseph Keshet1.   

Abstract

Automatic speech recognition (ASR) is increasingly becoming an integral component of our daily lives. This trend is in large part due to recent advances in machine learning, and specifically in deep learning, that have led to accurate ASR across numerous tasks. This has led to renewed interest in providing technological support to populations whose speech patterns are atypical, including identifying the presence of a specific pathology and its severity, comparing speech characteristics before and after a surgery and enhancing the quality of life of individuals with speech pathologies. The purpose of this primer is to bring readers with relatively little technical background up to speed on fundamentals and recent advances in ASR. It presents a detailed account of the anatomy of modern ASR, with examples of how it has been used in speech-language pathology research.

Keywords:  assessment of speech intelligibility; automatic speech recognition; monitoring; speech pathologies

Mesh:

Year:  2018        PMID: 31274357     DOI: 10.1080/17549507.2018.1510033

Source DB:  PubMed          Journal:  Int J Speech Lang Pathol        ISSN: 1754-9507            Impact factor:   2.484


  3 in total

1.  Automatic speech recognition in the operating room - An essential contemporary tool or a redundant gadget? A survey evaluation among physicians in form of a qualitative study.

Authors:  Antonia Schulte; Rodrigo Suarez-Ibarrola; Daniel Wegen; Philippe-Fabian Pohlmann; Elina Petersen; Arkadiusz Miernik
Journal:  Ann Med Surg (Lond)       Date:  2020-09-13

2.  Performance of Forced-Alignment Algorithms on Children's Speech.

Authors:  Tristan J Mahr; Visar Berisha; Kan Kawabata; Julie Liss; Katherine C Hustad
Journal:  J Speech Lang Hear Res       Date:  2021-03-11       Impact factor: 2.297

3.  Data mining of an acoustic biomarker in tongue cancers and its clinical validation.

Authors:  Yudong Xiao; Tao Wang; Wei Deng; Le Yang; Bin Zeng; Xiaomei Lao; Sien Zhang; Xiangqi Liu; Daiqiao Ouyang; Guiqing Liao; Yujie Liang
Journal:  Cancer Med       Date:  2021-05-02       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.